1. Wolfe D. Superfoods:The Food and Medicines of the Future. California: North Atlantic Books Berkeley; 2009. [Google Scholar]
2. Li Y, Zhang JJ, Xu DP, Zhou T, Zhou Y, Li S, et al. Bioactivities and health benefits of wild fruits. Int J Mol Sci. 2016;17:1–27. [PMC free article] [PubMed] [Google Scholar]
3. Syed IB. Spiritual medicine in the history of Islamic medicine. J Int Soc History Islamic Med. 2003;2:45–50. [Google Scholar]
4. Deuraseh N. Health and medicine in the Islamic tradition based on the book of medicine Kitab Al-tibb of Sahih Al-Bukhari. J Int Soc History Islamic Med. 2006;5:2–14. [Google Scholar]
5. Sarkhel S. Ethnomedicinal uses of some plants in treatment of jaundice by tribal communities of Paschim Medinipur district, West Bengal, India. Med Aromat Plants. 2015;4:1–4. [Google Scholar]
6. Saad B, Azaizeh H, Said O. Tradition and perspective of Arab herbal medicine:A review. Evid based Complement Altern Med. 2005;2:475–9. [PMC free article] [PubMed] [Google Scholar]
7. Gibbs JB, Oliff A. Pharmaceutical research in molecular oncology. Cell. 1994;79:193–8. [PubMed] [Google Scholar]
8. Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, et al. Trends and patterns of disparities in cancer mortality among US counties 1980-2014. JAMA. 2017;317:388–406. [PMC free article] [PubMed] [Google Scholar]
9. Feng SS, Chienc S. Chemotherapeutic engineering:Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci. 2003;58:4087–114. [Google Scholar]
10. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631–51. [PubMed] [Google Scholar]
11. Aghabati N, Mohammadi E, Esmaiel ZP. The effect of therapeutic touch on pain and fatigue of cancer patients undergoing chemotherapy. Evid Based Complement Altern Med. 2010;7:375–81. [PMC free article] [PubMed] [Google Scholar]
12. Krawczuk-Rybak M, Tomczuk-Ostapczuk M, Panasiuk A, Goscik E. Carotid intima-media thickness in young survivors of childhood cancer. J Med Imaging Radiat Oncol. 2016 DOI:10.1111/1754-9485.12510. [PubMed] [Google Scholar]
13. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes:Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. [PubMed] [Google Scholar]
14. Kasuga M. Insulin resistance and pancreatic beta cell failure. J Clin Invest. 2006;116:1756–60. [PMC free article] [PubMed] [Google Scholar]
15. Bailey CJ, Day C. Antidiabetic drugs. Br J Cardiol. 2003;10:128–36. [Google Scholar]
16. Hermansen K, Mortensen LS, Hermansen ML. Combining insulins with oral antidiabetic agents:Effect on hyperglycemic control, markers of cardiovascular risk and disease. Vasc Health Risk Manag. 2008;4:561–74. [PMC free article] [PubMed] [Google Scholar]
17. Meece J. Dispelling myths and removing barriers about insulin in Type 2 diabetes. Diabetes Educ. 2006;32:9S–18. [PubMed] [Google Scholar]
18. Shi Z, Ma L, Wang H, Yang Y, Li X, Schreiber A, et al. Insulin and hypertonic glucose in the management of aseptic fat liquefaction of post-surgical incision:A meta-analysis and systematic review. Int Wound J. 2013;10:91–7. [PMC free article] [PubMed] [Google Scholar]
19. Wong CY, Martinez J, Dass CR. Oral delivery of insulin for treatment of diabetes:Status quo, challenges and opportunities. J Pharm Pharmacol. 2016;68:1093–108. [PubMed] [Google Scholar]
20. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–209. [PubMed] [Google Scholar]
21. Kushner RF, Bessesen DH. Treatment of the obese patient. Endocrinology. 2009;158:916–29. [Google Scholar]
22. Bergmann KL, Cox SJ, Tabone LE. Influence of a rural environment on patient access and outcomes for bariatric surgery. Surg Obeset Relat Dis. 2016;S1550-S(7289):30812–7. [PubMed] [Google Scholar]
23. Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery:Current evidence. Cleve Clin J Med. 2006;73:993–1007. [PubMed] [Google Scholar]
24. Cepeda-Lopez AC, Allende-Labastida J, Melse-Boonstra A, Osendarp SJ, Herter-Aeberli I, Moretti D, et al. The effects of fat loss after bariatric surgery on inflammation, serum hepcidin, and iron absorption:A prospective 6-mo iron stable isotope study. Am J Clin Nutr. 2016;104:1030–8. [PubMed] [Google Scholar]
25. Loya AM, González-Stuart A, Rivera JO. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border:A descriptive, questionnaire-based study. Drugs Aging. 2009;26:423–36. [PubMed] [Google Scholar]
26. Cohen PA, Ernst E. Safety of herbal supplements:A guide for cardiologists. Cardiovasc Ther. 2010;28:246–53. [PubMed] [Google Scholar]
27. Son MJ, Im HJ, Kim YE, Ku B, Lee JH, Son CG. Evaluation of the anti-fatigue effects of a traditional herbal drug, Gongjin-Dan, under insufficient sleep conditions:Study protocol for a randomised controlled trial. Trials. 2016;17:418. [PMC free article] [PubMed] [Google Scholar]
28. Vayalil PK. Antioxidant and antimutagenic properties of aqueous extract of date fruit (Phoenix dactylifera L Arecaceae) J Agric Food Chem. 2002;50:610–7. [PubMed] [Google Scholar]
29. Al-Farsi MA, Lee CY. Nutritional and functional properties of dates:A review. Crit Rev Food Sci Nutr. 2008;48:877–87. [PubMed] [Google Scholar]
30. Al-Farsi M, Alasalvar C, Morris A, Baron M, Shahidi F. Comparison of antioxidant activity, anthocyanins, carotenoids, and phenolics of three native fresh and sun-dried date (Phoenix dactylifera L.) varieties grown in oman. J Agric Food Chem. 2005;53:7592–9. [PubMed] [Google Scholar]
31. Hanano A, Almousally I, Shaban M, Rahman F, Hassan M, Murphy DJ. Specific caleosin/peroxygenase and lipoxygenase activities are tissue-differentially expressed in date palm (Phoenix dactylifera L.) seedlings and are further induced following exposure to the toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin. Front Plant Sci. 2017;7:2025. [PMC free article] [PubMed] [Google Scholar]
32. Eid N, Enani S, Walton G, Corona G, Costabile A, Gibson G, et al. The impact of date palm fruits and their component polyphenols, on gut microbialecology, bacterial metabolites and colon cancer cell proliferation. J Nutr Sci. 2014;3:1–9. [PMC free article] [PubMed] [Google Scholar]
33. Khan F, Ahmed F, Pushparaj PN, Abuzenadah A, Kumosani T, Barbour E, et al. Ajwa date (Phoenix dactylifera L.) extract inhibits human breast adenocarcinoma (MCF7) cells in vitro by inducing apoptosis and cell cycle arrest. PLoS One. 2016;11:e0158963. [PMC free article] [PubMed] [Google Scholar]
34. Ishurd O, Zgheel F, Kermagi A, Flefla M, Elmabruk M. Antitumor activity of β-D-glucan from Libyan dates. J Med Food. 2004;7:252–5. [PubMed] [Google Scholar]
35. Saafi EB, Louedi M, Elfeki A, Zakhama A, Najjar MF, Hammami M, et al. Protective effect of date palm fruit extract (Phoenix dactylifera L.). on dimethoate induced-oxidative stress in rat liver. Exp Toxicol Pathol. 2011;63:433–41. [PubMed] [Google Scholar]
36. Ahmed AF, Al-Qahtani JH, Al-Yousef HM, Al-Said MS, Ashour AE, Al-Sohaibani M, et al. Proanthocyanidin-rich date seed extract protects against chemically induced hepatorenal toxicity. J Med Food. 2015;18:280–9. [PMC free article] [PubMed] [Google Scholar]
37. Miller CJ, Dunn EV, Hashim IB. The glycaemic index of dates and date/yoghurt mixed meals. Are dates 'the candy that grows on trees'? Eur J Clin Nutr. 2003;57:427–30. [PubMed] [Google Scholar]
38. Ovbiagele B, Markovic D, Fonarow GC. Recent US patterns and predictors of prevalent diabetes among acute myocardial infarction patients. Cardiol Res Pract. 2011;2011:145615. [PMC free article] [PubMed] [Google Scholar]
39. Hasan M, Mohieldein AB. In vivo evaluation of anti diabetic, hypolipidemic, antioxidative activities of Saudi date seed extract on streptozotocin induced diabetic rats. J Clin Diagn Res. 2016;10:6–12. [PMC free article] [PubMed] [Google Scholar]
40. El-Moughy SA, Abdel-Aziz SA, Al-Shanawany M, Omar A. The gonadotropic activity of palmae in mature rats. Alex J Pharm Res. 1991;5:156–9. [Google Scholar]
41. Al-Kuran O, Al-Mehaisen L, Bawadi H, Beitawi S, Amarin Z. The effect of late pregnancy consumption of date fruit on labour and delivery. J Obstet Gynaecol. 2011;31:29–31. [PubMed] [Google Scholar]
42. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, et al. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr. 2004;134:613–7. [PubMed] [Google Scholar]
43. Lansky EP, Newman RA. Punica granatum (Pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109:177–206. [PubMed] [Google Scholar]
44. Zahin M, Ahmad I, Gupta RC, Aqil F. Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts. Biomed Res Int. 2014;2014:467465. [PMC free article] [PubMed] [Google Scholar]
45. Dai Z, Nair V, Khan M, Ciolino HP. Pomegranate extract inhibits the proliferation and viability of MMTV-wnt-1 mouse mammary cancer stem cells in vitro. Oncol Rep. 2010;24:1087–91. [PubMed] [Google Scholar]
46. Sadik NA, Shaker OG. Inhibitory effect of a standardized pomegranate fruit extract on Wnt signalling 1,2 dimethyl hydrazine induced rat colon carcinogenesis. Dig Dis Sci. 2013;58:2507–17. [PubMed] [Google Scholar]
47. Bhatia D, Thoppil RJ, Mandal A, Samtani KA, Darvesh AS, Bishayee A. Pomegranate bioactive constituents suppress cell proliferation and induce apoptosis in an experimental model of hepatocellular carcinoma:Role of Wnt/βcatenin signalling pathway. Evid Based Complement Altern Med. 2013;2013:1–15. [PMC free article] [PubMed] [Google Scholar]
48. George J, Singh M, Srivastava AK, Bhui K, Shukla Y. Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide:Evidence for inhibition of activated MAPKs/NF-kB and reduced cell proliferation. Food Chem Toxicol. 2011;49:1511–20. [PubMed] [Google Scholar]
49. Dahlawi H, Jordan-Mahy N, Clench MR, Le Maitre CL. Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia. Nutr Cancer. 2012;64:100–10. [PubMed] [Google Scholar]
50. West T, Atzeva M, Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci. 2007;29:363–72. [PMC free article] [PubMed] [Google Scholar]
51. Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr. 2013;143:597–605. [PMC free article] [PubMed] [Google Scholar]
52. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Cholesterol-lowering effect of concentrated pomegranate juice consumption in Type II diabetic patients with hyperlipidemia. Int J Vitam Nutr Res. 2006;76:147–51. [PubMed] [Google Scholar]
53. Ito H, Li P, Koreishi M, Nagatomo A, Nishida N, Yoshida T. Ellagitannin oligomers and a neolignan from pomegranate arils and their inhibitory effects on the formation of advanced glycation end products. Food Chem. 2013;152:323–30. [PubMed] [Google Scholar]
54. Kumagai Y, Nakatani S, Onodera H, Nagatomo A, Nishida N, Matsura Y, et al. Anti-glycation effects of Pomegranate (Punica granatum L.) fruit extract and its components in vivo and in vitro. J Agric Food Chem. 2015;63:7760–4. [PubMed] [Google Scholar]
55. Stowe CB. The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement Ther Clin Pract. 2011;17:113–5. [PubMed] [Google Scholar]
56. Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S, Rafieian-Kopaei M, et al. Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res. 2014;28:193–9. [PubMed] [Google Scholar]
57. Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases:Studies in atherosclerotic mice and in humans. Drugs Exp Clin Res. 2002;28:49–62. [PubMed] [Google Scholar]
58. Sparwel J, Vantler M, Caglayan E, Kappert K, Fries JW, Dietrich H, et al. Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor:Impact of the mash fermentation. Cardiovasc Res. 2009;81:758–70. [PubMed] [Google Scholar]
59. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995;155:381–6. [PubMed] [Google Scholar]
60. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D. Catechin intake and associated dietary and lifestyle factors in a representative sample of Dutch men and women. Eur J Clin Nutr. 2001;55:76–81. [PubMed] [Google Scholar]
61. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction:The Rotterdam study. Am J Clin Nutr. 2002;75:880–6. [PubMed] [Google Scholar]
62. Blumberg JB, Vita JA, Chen CY. Concord grape juice polyphenols and cardiovascular risk factors:Dose-response relationships. Nutrients. 2015;7:10032–52. [PMC free article] [PubMed] [Google Scholar]
63. Rasines-Perea Z, Teissedre PL. Grape polyphenols'effects in human cardiovascular diseases and diabetes. Molecules. 2017;22:E68. [PMC free article] [PubMed] [Google Scholar]
64. Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice:Relationship to decreased fat and lipid peroxidation. Carcinogenesis. 2003;24:1379–88. [PubMed] [Google Scholar]
65. Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis. 2006;27:1682–91. [PubMed] [Google Scholar]
66. Raina K, Singh RP, Agarwal R, Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice. Cancer Res. 2007;67:5976–82. [PubMed] [Google Scholar]
67. Sun Q, Prasad R, Rosenthal E, Katiyar SK. Grape seed proanthocyanidins inhibit the invasiveness of human HNSCC cells by targeting EGFR and reversing the epithelial-to-mesenchymal transition. PLoS One. 2012;7:e31093. [PMC free article] [PubMed] [Google Scholar] Retracted
68. Prasad R, Katiyar SK. Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules. PLoS One. 2012;7:e46404. [PMC free article] [PubMed] [Google Scholar]
69. Sharma SD, Meeran SM, Katiyar SK. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors. Mol Cancer Ther. 2010;9:569–80. [PubMed] [Google Scholar]
70. Mao JT, Xue B, Lu JS, Park H, Henning SM, Burns W, et al. MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer. JNutr Biochem. 2016;34:118–25. [PMC free article] [PubMed] [Google Scholar]
71. Orhan N, Aslan M, Orhan DD, Ergun F, Yeşilada E. In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats. J Ethnopharmacol. 2006;108:280–6. [PubMed] [Google Scholar]
72. Zunino SJ. Type 2 diabetes and glycemic response to grapes or grape products. J Nutr. 2009;26:1794–800. [PubMed] [Google Scholar]
73. Dohadwala MM, Vita JA. Grapes and cardiovascular disease. J Nutr. 2009;139:1788S–93. [PMC free article] [PubMed] [Google Scholar]
74. Dohadwala MM, Hamburg NM, Holbrook M, Kim BH, Duess MA, Levit A, et al. Effects of concord grape juice on ambulatory blood pressure in prehypertension and stage 1 hypertension. Am J Clin Nutr. 2010;92:1052–9. [PMC free article] [PubMed] [Google Scholar]
75. Goreja WG. Black Seed:Nature's Miracle Remedy. New York, NY: Amazing Herbs Press; 2003. [Google Scholar]
76. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants used in Ayurveda. New Delhi: Central Council for Research in Ayurveda &Siddha, Department of ISM &H, Ministry of Health & Family Welfare, Government of India; 2005. pp. 420–40. [Google Scholar]
77. Pari L, Sankaranarayanan C. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 2009;85:830–4. [PubMed] [Google Scholar]
78. Kanter M, Akpolat M, Aktas C. Protective effects of the volatile oil of Nigella sativa seeds on beta-cell damage in streptozotocin-induced diabetic rats:A light and electron microscopic study. J Mol Histol. 2009;40:379–85. [PubMed] [Google Scholar]
79. Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with Type 2 diabetes mellitus. Indian J Physiol Pharmacol. 2010;54:344–54. [PubMed] [Google Scholar]
80. Salama RH. Hypoglycemic effect of lipoic acid, carnitine and Nigella sativa in diabetic rat model. Int J Health Sci (Qassim) 2011;5:126–34. [PMC free article] [PubMed] [Google Scholar]
81. Salim EI. Cancer chemopreventive potential of volatile oil from black cumin seeds Nigella sativa L. In a rat multi-organ carcinogenesis bioassay. Oncol Lett. 2010;1:913–24. [PMC free article] [PubMed] [Google Scholar]
82. Mahmoud SS, Torchilin VP. Hormetic/cytotoxic effects of Nigella sativa seed alcoholic and aqueous extracts on MCF-7 breast cancer cells alone or in combination with doxorubicin. Cell Biochem Biophys. 2012;25:1392–8. [PubMed] [Google Scholar]
83. Ali SA, Metei KV. Nigella sativa seed extract and its bioactive compound thymoquinone:The new melanogens causing hyperpigmentation in the wall lizard melanophores. J Pharm Pharmacol. 2011;63:741–6. [PubMed] [Google Scholar]
84. Joseph B, Raj SJ. A comparative study on various properties of five medicinally important plants. Int J Pharm. 2011;7:206–11. [Google Scholar]
85. Rubnov S, Kashman Y, Rabinowitz R, Schlesinger M, Mechoulam R. Suppressors of cancer cell proliferation from fig (Ficus carica) resin:Isolation and structure elucidation. J Nat Prod. 2001;64:993–6. [PubMed] [Google Scholar]
86. Yancheva SD, Golubowicz S, Yablowicz Z, Perl A. Efficient agrobacterium-mediated transformation and recovery of transgenic fig (Ficus carica L.) plants. Plant Sci. 2005;168:1433–41. [Google Scholar]
87. Jing L, Zhang YM, Luo JG, Kong LY. Tirucallane-type triterpenoids from the fruit of Ficus carica and their cytotoxic activity. Chem Pharm Bull (Tokyo) 2015;63:237–43. [PubMed] [Google Scholar]
88. Tezcan G, Tunca B, Bekar A, Yalcin M, Sahin S, Budak F, et al. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines. Cell Mol Neurobiol. 2015;35:175–87. [PubMed] [Google Scholar]
89. Perez C, Domınguez E, Ramiro JM, Romero A, Campillo JE, Torres MD. A study on the glycaemic balance in streptozotocin-diabetic rats treated with an aqueous extract of Ficus carica (figtree) leaves. Phytother Res. 1998;10:82–3. [Google Scholar]
90. Pèrez C, Canal JR, Torres MD. Experimental diabetes treated with Ficuscarica extract:Effect on oxidative stress parameters. Acta Diabetol. 2003;40:3–8. [PubMed] [Google Scholar]
91. Irudayaraj SS, Stalin A, Sunil C, Duraipandiyan V, Al-Dhabi NA, Ignacimuthu S. Antioxidant, antilipidemic and antidiabetic effects of ficusin with their effects on GLUT4 translocation and PPARγexpression in Type 2 diabetic rats. Chem Biol Interact. 2016;256:85–93. [PubMed] [Google Scholar]
92. Pérez C, Canal JR, Campillo JE, Romero A, Torres MD. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridemia rats. Phytother Res. 1999;13:188–91. [PubMed] [Google Scholar]
93. Asadi F, Pourkabir M, Maclaren R, Shahriari A. Alterations to lipid parameters in response to fig tree (Ficus carica) leaf extract in chicken liver slices. Turk J Vet Anim Sci. 2006;30:315–8. [Google Scholar]
94. Meitei KV, Ali SA. Fig leaf extract and its bioactive compound psoralen induces skin darkening effect in reptilian melanophores via cholinergic receptor stimulation. In Vitro Cell Dev Biol Anim. 2012;48:335–9. [PubMed] [Google Scholar]
95. La Vecchia C. Mediterranean diet and cancer. Public Health Nutr. 2004;7:965–8. [PubMed] [Google Scholar]
96. Visioli F, Grande S, Bogani P, Galli C. The role of antioxidants in the Mediterranean dates:Focus on cancer. Eur J Cancer Prev. 2004;13:337–43. [PubMed] [Google Scholar]
97. Menendez JA, Vazquez-Martin A, Garcia-Villalba R, Carrasco-Pancorbo A, Oliveras-Ferraros C, Fernandez-Gutierrez A, et al. TabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial extra-virgin olive oil (EVOO) BMC Cancer. 2008;8:377. [PMC free article] [PubMed] [Google Scholar]
98. Wahle KW, Caruso D, Ochoa JJ, Quiles JL. Olive oil and modulation of cell signaling in disease prevention. Lipids. 2004;39:1223–31. [PubMed] [Google Scholar]
99. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21:131–6. [PubMed] [Google Scholar]
100. Pitt J, Roth W, Lacor P, Blankenship M, Velasco P, de Felice F, et al. Alzheimer's-associated Aβoligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharm. 2009;240:189–97. [PMC free article] [PubMed] [Google Scholar]
101. Donato-Trancoso A, Monte-Alto-Costa A, Romana-Souza B. Olive oil-induced reduction of oxidative damage and inflammation promotes wound healing of pressure ulcers in mice. J Dermatol Sci. 2016;83:60–9. [PubMed] [Google Scholar]
102. Briante R, Patumi M, Terenziani S, Bismuto E, Febbraio F, Nucci R, et al. Olea europaea L. Leaf extract and derivatives:Antioxidant properties. J Agric Food Chem. 2002;17:4934–40. [PubMed] [Google Scholar]
103. Jemai H, El Feki A, Sayadi S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 2009;57:8798–804. [PubMed] [Google Scholar]
